 it's hard to sort of do systematic studies. There are some really great examples. There was a really great study of a drug that's used with sepsis and the researchers looked at what happened after there was a severe shortage and patients were switched to another drug and they saw mortality rates significantly go up. There's an unpublished analysis by the FDA that took the number of deaths that resulted and did an estimate of this one shortage in terms of the costs